A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

Clinical trial NCT05463263 · RECRUITING

Trial details

NCT number: NCT05463263
Sponsor: Step Pharma, SAS
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma, B-Cell Lymphoma, T-Cell

Start date: 2022-08-03
Primary completion: 2026-12-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.